USANA Health Sciences, Inc.

NYSE:USNA

Packaged Foods

Consumer Defensive
$13.22 +3.83%

+$0.71 today

Market cap
$244.42M
Beta
0.77
P/E (TTM)
39.6
EPS (TTM)
$0.48
52W Low $16.60High $38.32

Volume 0.15M

Average 0.12M

USNA Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

USANA Health Sciences, Inc.NYSE: USNA

Research & Development · Q1 FY2026 · quarter ended Apr 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, down 1.4 pp from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
$0— QoQ
Last fiscal yearJan 2026
$0-100.0% YoY
LTMApr 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Research & Development vs competitors

How USNA compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Research & development amounts to 0.0% of revenue for USNA, versus a peer median of 0.0%.
USNA Competitors
Research & Development for USNA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DDLDingdong (Cayman) LimitedLTM Mar 2026CN¥635.95M CNY-21.0%-6.4%3.3%
MAMAMama's Creations, Inc.LTM Apr 2026$302K USD-28.8%+28.7%0.2%
USNAUSANA Health Sciences, Inc.LTM Apr 2026$0 USD——0.0%
WESTWestrock Coffee Company, LLCLTM Mar 2026$0 USD——0.0%
LWAYLifeway Foods, Inc.LTM Mar 2026$0 USD——0.0%
LNDBrasilAgro - Companhia Brasileira de Propriedades AgrícolasLTM Mar 2026R$0 BRL——0.0%
BGSB&G Foods, Inc.LTM Apr 2026$0 USD——0.0%
BRCCBRC Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding USNA) —-24.9%+11.1%0.0%

Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue1.19B998.6M921.01M854.5M925.26M
Cost of Revenue230.93M207.28M189.4M175.75M200.85M
Gross Profit955.53M791.32M731.62M678.75M724.41M
Gross Margin80.5%79.2%79.4%79.4%78.3%
Research & Development11.11M11.56M11.45M11.57M0
Selling, General & Admin774.23M672.14M627.1M600.86M337.37M
Operating Expenses785.34M683.7M638.54M612.43M673.54M
Depreciation & Amortization22.19M21.41M20.4M22.23M39.7M
EBITDA192.89M130.22M123.11M98.86M82.07M
EBITDA Margin16.3%13.0%13.4%11.6%8.9%
Operating Income170.19M107.61M93.07M66.32M50.86M
Operating Margin14.3%10.8%10.1%7.8%5.5%
Interest Income2.52M3.79M9.64M11.32M2.42M
Interest Expense57K192K262K281K842K
Other Income / Expenses450K1.01M9.38M10.03M(9.34M)
Income Before Tax170.64M108.62M102.45M76.35M41.53M
Pre-Tax Margin14.4%10.9%11.1%8.9%4.5%
Income Tax Expense54.14M39.27M38.67M34.29M30.05M
Net Income116.51M69.35M63.79M42.03M10.76M
Net Margin9.8%6.9%6.9%4.9%1.2%
EPS (Basic)5.783.603.332.200.58
EPS (Diluted)5.733.593.302.190.58
Weighted Avg Shares20.15M19.25M19.25M19.06M18.57M
Weighted Avg Shares (Diluted)20.34M19.31M19.35M19.16M18.57M

USANA Health Sciences, Inc.

NYSE:USNA

Intrinsic Alpha fair value

Locked

Current Price

$13.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.